Glycosylated podophyllotoxin congeners: loss of microtubule inhibition and permission of invasion in vitro
Mareel, M.M.; Dragonetti, C.H.; De Bruyne, G.K.; Van Cauwenberge, R.M.
Journal of the National Cancer Institute 69(6): 1367-1374
1982
ISSN/ISBN: 0027-8874 PMID: 6958912 Document Number: 187390
Podophyllotoxin (PPT) and its glycosylated congeners, 4'-demethylepipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside] (VP-16-213) and 4'-demethylepipodophyllotoxin 9-[4,6-O-(R)-thenylidene-beta-D-glucopyranoside] (VM-26), were studied for their effects on the following activities of MO4 mouse fibrosarcoma cells in vitro: growth as an aggregate in culture on a gyrotory shaker, directional migration from an aggregate explanted on glass, organization of the cytoplasmic microtubule complex as inferred from immunostaining with an antiserum against tubulin, and invasion into fragments of 9-day-old embryonic chick cardiac muscle. At concentrations that inhibited growth (greater than or equal to 0.03 microgram/ml), PPT arrested directional migration, abolished the cytoplasmic microtubule complex, and interfered with invasion. VM-26 (0.1-1.0 microgram/ml) and VP-16-213 (1-30 micrograms/ml) interfered with growth but permitted directional migration, organization of the cytoplasmic microtubule complex, and invasion. These observations imply that microtubule inhibitors are anti-invasive because they interfere with the assembly of the cytoplasmic microtubule complex and not because they inhibit growth.